In vitro models can be a helpful tool for recreating the conditions of Alzheimer's disease (AD). However, many systems fail to incorporate neuroinflammation mechanisms into their design. Park et al. designed a triculture system utilizing neurons and astrocytes, differentiated from progenitor cells, and microglia. This model exhibited key AD symptoms like amyloid beta aggregate and phospho Tau formation. Factors like CCL2 and ATP were also produced and drew in microglia from an outer chamber. Microglia then promoted inflammation and reduced the overall neuron and astrocyte count. Park et al. are hoping this improved model system provides a more accurate representation of AD development, aiding in future potential therapies. BioLegend is committed to advancing AD research by providing reagents to study cells of the CNS and identify protein aggregates in neurodegenerative diseases.


Adapted from Park, J. et al. 2018. Nat. Neurosci. 21:941. Pubmed
Amyloid Beta Reagents
β-Amyloid, 1-15 Antibody (aggregate-preferring)
β-Amyloid, 1-16 Antibody
β-Amyloid, 1-42 Antibody
β-Amyloid, 17-24 Antibody
LEGEND MAX™ β-Amyloid x-40 ELISA Kit
LEGEND MAX™ β-Amyloid x-42 ELISA Kit
Phospho Tau Antibodies Cytokines
Tau Phospho (Thr181) CCL2
Tau Phospho (Thr231) CXCL10
Tau Phospho (Ser262) CX3CL1
Tau Phospho (Ser396) IFN-γ
Tau Antibody Sampler Kit TNF-α
Additional Neuroscience Markers
Glial Cell Marker Antibody Sampler Kit
CD11b
CD68
GFAP
MAP2
TLR4
Tubulin Beta 3
If you're looking to learn more about these vital CNS cells involved in the outcome of Alzheimer's disease, check out our webpages on Microglia and Astrocytes! Or, if you're determined to learn more about protein aggregates, take a look at our Amyloid Beta and Tau webpages.
*Any references to promotions on this page may not be valid at this time. View our promotions page for the most up-to-date promotions.
Login/Register
Forgot your password? Reset Password
Request an Account